The resignation of head drug regulator George Tidmarsh comes amid concerns about conduct related to the lupus nephritis drug ...
The drama continued Monday with senior FDA leaders as more details emerged about former Center for Drug Evaluation and ...
Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical ...
Dr. George Tidmarsh, the FDA's top drug regulator, was placed on leave amid controversy over the drug approval process and a ...
George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the ...
It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...
The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...
The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his ...
HealthDay on MSN
Top FDA Drug Chief Resigns While Under Investigation
Key Takeaways Dr. George Tidmarsh resigned Sunday while under investigationTidmarsh says he was targeted after questioning a ...
Head of FDA’s drug center George Tidmarsh is the latest member to see his name in headlines. On Friday, October 31, FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback